- Presentations
- 0
- Brands
- 0
- Manufacturers
- 0
- Available from stock
- 0
Vilobelimab is a medicine. It is available for export supply from India to licensed hospitals, importers and physicians, with the documents the destination country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Key facts
- ATC classification
- L04AJ10 Vilobelimab · Immunosuppressive drug, subgroup L04AJ
- US FDA first approval
- Not recorded
- EU status
- Authorised
- Orphan designation
- No
- WHO essential medicine
- Not recorded
- India (CDSCO)
- Not yet confirmed against CDSCO approval lists
All presentations
No presentations of Vilobelimab are listed yet. Ask us to source it
Regulatory status
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
Questions and answers
Is Vilobelimab available for export from India?
No presentation of Vilobelimab is listed yet, but our sourcing team can check licensed channels. Send a request with the strength, quantity and destination country.
Is Vilobelimab authorised in the European Union?
Yes. Vilobelimab has a central EU marketing authorisation (status: authorised), according to European Medicines Agency data.
Does Vilobelimab need cold chain shipping?
No listed presentation of Vilobelimab is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Which ATC class is Vilobelimab in?
Vilobelimab is classified under ATC code L04AJ10 (Vilobelimab).
References
- Gohibic: European public assessment report (EPAR). European Medicines Agency. Retrieved 17 March 2026
Request Vilobelimab for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.